Sustained efficacy of the pentavalent rotavirus vaccine, RV5, up to 3.1 years following the last dose of vaccine.

Vesikari, Timo

Sustained efficacy of the pentavalent rotavirus vaccine, RV5, up to 3.1 years following the last dose of vaccine. [electronic resource] - The Pediatric infectious disease journal Oct 2010 - 957-63 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1532-0987

10.1097/INF.0b013e3181e28e6e doi


Female
Finland--epidemiology
Follow-Up Studies
Hospitalization--statistics & numerical data
Humans
Infant
Infant, Newborn
Male
Rotavirus Infections--epidemiology
Rotavirus Vaccines--immunology
Time Factors
Vaccines, Attenuated--immunology